114 related articles for article (PubMed ID: 29777112)
1. MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer.
Lin HM; Nikolic I; Yang J; Castillo L; Deng N; Chan CL; Yeung NK; Dodson E; Elsworth B; Spielman C; Lee BY; Boyer Z; Simpson KJ; Daly RJ; Horvath LG; Swarbrick A
Sci Rep; 2018 May; 8(1):7820. PubMed ID: 29777112
[TBL] [Abstract][Full Text] [Related]
2. Novel actions of next-generation taxanes benefit advanced stages of prostate cancer.
de Leeuw R; Berman-Booty LD; Schiewer MJ; Ciment SJ; Den RB; Dicker AP; Kelly WK; Trabulsi EJ; Lallas CD; Gomella LG; Knudsen KE
Clin Cancer Res; 2015 Feb; 21(4):795-807. PubMed ID: 25691773
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid binding protein 5 regulates docetaxel sensitivity in taxane-resistant prostate cancer cells.
Hillowe A; Gordon C; Wang L; Rizzo RC; Trotman LC; Ojima I; Bialkowska A; Kaczocha M
PLoS One; 2023; 18(10):e0292483. PubMed ID: 37796964
[TBL] [Abstract][Full Text] [Related]
4. Exploration of the influence of GOLGA8B on prostate cancer progression and the resistance of castration-resistant prostate cancer to cabazitaxel.
Li H; Wang X; Zhai M; Xu C; Chen X
Discov Oncol; 2024 May; 15(1):152. PubMed ID: 38730195
[TBL] [Abstract][Full Text] [Related]
5. Non-Coding RNAs and the Development of Chemoresistance to Docetaxel in Prostate Cancer: Regulatory Interactions and Approaches Based on Machine Learning Methods.
Pudova E; Kobelyatskaya A; Emelyanova M; Snezhkina A; Fedorova M; Pavlov V; Guvatova Z; Dalina A; Kudryavtseva A
Life (Basel); 2023 Dec; 13(12):. PubMed ID: 38137905
[TBL] [Abstract][Full Text] [Related]
6. miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson's disease.
Suvarna V; Deshmukh K; Murahari M
Front Pharmacol; 2022; 13():1034072. PubMed ID: 36506536
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Epithelial-to-Mesenchymal Transition and Chemoresistance in Advanced Retinoblastoma Tumors Is Driven by miR-181a.
Suresh Babu V; Bisht A; Mallipatna A; Sa D; Dudeja G; Kannan R; Shetty R; Guha N; Heymans S; Ghosh A
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291907
[TBL] [Abstract][Full Text] [Related]
8. Exploring MicroRNA and Exosome Involvement in Malignant Pleural Mesothelioma Drug Response.
Johnson B; Zhuang L; Rath EM; Yuen ML; Cheng NC; Shi H; Kao S; Reid G; Cheng YY
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230710
[TBL] [Abstract][Full Text] [Related]
9. Targeting of Mcl-1 Expression by MiRNA-3614-5p Promotes Cell Apoptosis of Human Prostate Cancer Cells.
Hsieh YH; Yu FJ; Nassef Y; Liu CJ; Chen YS; Lin CY; Feng JL; Wu MH
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457012
[TBL] [Abstract][Full Text] [Related]
10. Screening key miRNAs and genes in prostate cancer by microarray analysis.
Wu J; Li X; Luo F; Yan J; Yang K
Transl Cancer Res; 2020 Feb; 9(2):856-868. PubMed ID: 35117431
[TBL] [Abstract][Full Text] [Related]
11. Combined Ultrasound Treatment with Transferrin-Coupled Nanoparticles Improves Active Targeting of 4T1 Mammary Carcinoma Cells.
Jin X; Yu J; Yin M; Sinha A; Jin G
Technol Cancer Res Treat; 2021; 20():15330338211062325. PubMed ID: 34825851
[No Abstract] [Full Text] [Related]
12. Long non-coding RNA HEIH: a novel tumor activator in multiple cancers.
Sun JY; Ni MM
Cancer Cell Int; 2021 Oct; 21(1):558. PubMed ID: 34689775
[TBL] [Abstract][Full Text] [Related]
13. Role of Metastasis-Related microRNAs in Prostate Cancer Progression and Treatment.
Oh-Hohenhorst SJ; Lange T
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503302
[TBL] [Abstract][Full Text] [Related]
14. A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer.
Crowley F; Sterpi M; Buckley C; Margetich L; Handa S; Dovey Z
Res Rep Urol; 2021; 13():457-472. PubMed ID: 34235102
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Taxane Resistance.
Maloney SM; Hoover CA; Morejon-Lasso LV; Prosperi JR
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182737
[TBL] [Abstract][Full Text] [Related]
16. The Role of MicroRNAs in Repair Processes in Multiple Sclerosis.
Duffy CP; McCoy CE
Cells; 2020 Jul; 9(7):. PubMed ID: 32708794
[TBL] [Abstract][Full Text] [Related]
17. Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders.
Paul S; Bravo Vázquez LA; Pérez Uribe S; Roxana Reyes-Pérez P; Sharma A
Cells; 2020 Jul; 9(7):. PubMed ID: 32679881
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Multidrug Resistance in Cancer Chemotherapy.
Bukowski K; Kciuk M; Kontek R
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370233
[TBL] [Abstract][Full Text] [Related]
19. FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer.
Ma L; He H; Jiang K; Jiang P; He H; Feng S; Chen K; Shao J; Deng G
Aging (Albany NY); 2020 Apr; 12(7):6352-6369. PubMed ID: 32283544
[TBL] [Abstract][Full Text] [Related]
20. Resistance Mechanisms to Taxanes and PARP Inhibitors in Advanced Prostate Cancer.
Lombard AP; Gao AC
Curr Opin Endocr Metab Res; 2020 Feb; 10():16-22. PubMed ID: 32258820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
